GSK, Theravance begin phase-III programme to develop next general treatment … – pharmabiz.com
GSK, Theravance begin phase-III programme to develop next general treatment ... pharmabiz.com In addition to the COPD development programme, GSK and Theravance remain committed to the progression of the Horizon programme for the treatment of asthma ... |